Clinical Trials Analysis Breast Cancer accounts for 12.2% share of global Oncology clinical trial activity in 2020
Clinical Trials Analysis Lupus Erythematosus accounts for 8.2% share of global Immunology clinical trial activity in 2020
Clinical Trials Analysis Schizophrenia accounts for 2.9% share of global Central Nervous System clinical trial activity in 2020
Clinical Trials Analysis Depression accounts for 7.6% share of global Central Nervous System clinical trial activity in 2020
Clinical Trials Analysis Prostate Cancer accounts for 4.5% share of global Oncology clinical trial activity in 2020
Clinical Trials Analysis Pain accounts for 47.7% share of global Central Nervous System clinical trial activity in 2020
Clinical Trials Analysis Ovarian Cancer accounts for 4.4% share of global Oncology clinical trial activity in 2020
Clinical Trials Analysis Lymphoma accounts for 9.8% share of global Oncology clinical trial activity in 2020
Clinical Trials Analysis Leukemia accounts for 10.6% share of global Oncology clinical trial activity in 2020
Clinical Trials Analysis Psoriasis accounts for 17.5% share of global Immunology clinical trial activity in 2020
Clinical Trials Analysis Stroke accounts for 12.6% share of global Cardiovascular clinical trial activity in 2020
Clinical Trials Analysis Rheumatoid Arthritis accounts for 18.9% share of global Immunology clinical trial activity in 2020
Clinical Trials Analysis Osteoarthritis accounts for 26.2% share of global Musculoskeletal Disorders clinical trial activity in 2020
Clinical Trials Analysis Hepatitis C accounts for 0.9% share of global Infectious Disease clinical trial activity in 2020
Clinical Trials Analysis Asthma accounts for 13.4% share of global Respiratory clinical trial activity in 2020
Clinical Trials Analysis South Korea accounts for 3.6% share of global clinical trial activity in 2020
Clinical Trials Analysis Parkinson’s Disease accounts for 3.6% share of global Central Nervous System clinical trial activity in 2020
News EC approves Roche’s Evrysdi as first at-home treatment for spinal muscular atrophy Darcy Jimenez
Features Neutralising the gluten threat: are we on the cusp of a coeliac disease breakthrough? Allie Nawrat
Deals Analysis Beyond vaccines: SporeGen, Destiny partner on nasal spray to prevent Covid-19 Allie Nawrat
Features AstraZeneca pauses Covid-19 vaccine trials after unexplained participant illness Allie Nawrat
Features NeuroRx’s RLF-100: the key to treating and preventing Covid-19 respiratory failure? Allie Nawrat